J. A. Bohnert, B. Karamian, and H. Nikaido, Optimized Nile Red Efflux Assay of AcrAB-TolC Multidrug Efflux System Shows Competition between Substrates, Antimicrobial Agents and Chemotherapy, vol.54, issue.9, pp.3770-3775, 2010.
DOI : 10.1128/AAC.00620-10

J. A. Bohnert, S. Schuster, M. Szymaniak-vits, and W. V. Kern, Determination of Real-Time Efflux Phenotypes in Escherichia coli AcrB Binding Pocket Phenylalanine Mutants Using a 1,2???-Dinaphthylamine Efflux Assay, PLoS ONE, vol.11, issue.6, 2011.
DOI : 10.1371/journal.pone.0021196.t001

J. M. Brunel, A. Lieutaud, V. Lome, J. Pagès, and J. Bolla, Polyamino geranic derivatives as new chemosensitizers to combat antibiotic resistant Gram-negative bacteria, Bioorganic & Medicinal Chemistry, vol.21, issue.5, pp.1174-1179, 2013.
DOI : 10.1016/j.bmc.2012.12.030

K. Bush, P. Courvalin, G. Dantas, J. Davies, B. Eisenstein et al., Tackling antibiotic resistance, Nature Reviews Microbiology, vol.247, issue.12, pp.894-896, 1038.
DOI : 10.1126/science.2153314

L. Daury, F. Orange, J. C. Taveau, A. Verchère, L. Monlezun et al., Tripartite assembly of RND multidrug efflux pumps, Nature Communications, vol.464, 2016.
DOI : 10.1007/s00232-014-9707-3

URL : https://hal.archives-ouvertes.fr/hal-02150028

D. Pasquale, E. Salmi-smail, C. Brunel, J. Sanchez, P. Fantini et al., Biophysical studies of the interaction of squalamine and other cationic amphiphilic molecules with bacterial and eukaryotic membranes: importance of the distribution coefficient in membrane selectivity, Chemistry and Physics of Lipids, vol.163, issue.2, pp.131-140, 2010.
DOI : 10.1016/j.chemphyslip.2009.10.006

L. Ejim, M. A. Farha, S. B. Falconer, J. Wildenhain, B. K. Coombes et al., Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy, Nature Chemical Biology, vol.51, issue.6, pp.348-350, 2011.
DOI : 10.1111/j.1574-6968.1989.tb03412.x

A. Gilardi, S. P. Bhamidimarri, M. Brönstrup, U. Bilitewski, R. K. Marreddy et al., Biophysical characterization of E. coli TolC interaction with the known blocker hexaamminecobalt, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1861, issue.11, pp.2702-2709, 2017.
DOI : 10.1016/j.bbagen.2017.07.014

B. K. Gorityala, G. Guchhait, S. Goswami, D. M. Fernando, A. Kumar et al., by Enhancing Outer Membrane Penetration and Reducing Efflux, Journal of Medicinal Chemistry, vol.59, issue.18, pp.8441-8455, 2016.
DOI : 10.1021/acs.jmedchem.6b00867

A. L. Harvey, R. Edrada-ebel, Q. , R. J. Kusaka, Y. Yokota et al., The re-emergence of natural products for drug discovery in the genomics era, Nature Reviews Drug Discovery, vol.76, issue.2, pp.111-129, 2007.
DOI : 10.1021/np3006875

J. E. Kristiansen, O. Hendricks, T. Delvin, T. S. Butterworth, L. Aagaard et al., Reversal of resistance in microorganisms by help of non-antibiotics, Journal of Antimicrobial Chemotherapy, vol.12, issue.6, pp.1271-1279, 2007.
DOI : 10.1097/00002030-200206140-00002

K. Lewis, Platforms for antibiotic discovery, Nature Reviews Drug Discovery, vol.34, issue.5, pp.371-387, 2013.
DOI : 10.1111/j.1749-4486.2009.01973.x

O. Lomovskaya, H. I. Zgurskaya, M. Totrov, and W. J. Watkins, Waltzing transporters and 'the dance macabre' between humans and bacteria, Nature Reviews Drug Discovery, vol.43, issue.1, pp.56-65, 1038.
DOI : 10.1021/bi035965k

M. Mallea, J. Chevalier, C. Bornet, A. Eyraud, A. Davin-regli et al., Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes, Microbiology, vol.144, issue.11, pp.3003-3009, 1998.
DOI : 10.1099/00221287-144-11-3003

M. Masi, M. Refregiers, K. M. Pos, and J. Pagès, Mechanisms of envelope permeability and antibiotic influx and efflux in Gram-negative bacteria, Nature Microbiology, vol.3, issue.3, 2017.
DOI : 10.1073/pnas.0901695106

URL : https://hal.archives-ouvertes.fr/hal-01490432

Y. Matsumoto, K. Hayama, S. Sakakihara, K. Nishino, H. Noji et al., Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels, PLoS ONE, vol.51, issue.4, 2011.
DOI : 10.1371/journal.pone.0018547.t002

K. Mazumdar, S. G. Dastidar, J. H. Park, and N. K. Dutta, The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target, European Journal of Clinical Microbiology & Infectious Diseases, vol.31, issue.6B, pp.881-891, 2009.
DOI : 10.1016/0002-9343(86)90933-2

K. Nagano and H. Nikaido, Kinetic behavior of the major multidrug efflux pump AcrB of Escherichia coli, Proceedings of the National Academy of Sciences, vol.173, issue.18, pp.5854-5858, 2009.
DOI : 10.1128/jb.173.18.5631-5638.1991

H. Nikaido, Prevention of drug access to bacterial targets: permeability barriers and active efflux, Science, vol.264, issue.5157, 1994.
DOI : 10.1126/science.8153625

D. J. Payne, M. N. Gwynn, D. J. Holmes, and D. L. Pompliano, Drugs for bad bugs: confronting the challenges of antibacterial discovery, Nature Reviews Drug Discovery, vol.293, issue.1, pp.29-40, 1038.
DOI : 10.1126/science.1063566

J. M. Pogue, J. K. Ortwine, K. , and K. S. , Clinical considerations for optimal use of the polymyxins: A focus on agent selection and dosing, Clinical Microbiology and Infection, vol.23, issue.4, pp.229-233, 2017.
DOI : 10.1016/j.cmi.2017.02.023

E. Pradel and J. M. Pagès, The AcrAB-TolC Efflux Pump Contributes to Multidrug Resistance in the Nosocomial Pathogen Enterobacter aerogenes, Antimicrobial Agents and Chemotherapy, vol.46, issue.8, 2002.
DOI : 10.1128/AAC.46.8.2640-2643.2002

E. K. Schneider, F. Reyes-ortega, T. Velkov, L. , and J. , Antibioticnon-antibiotic combinations for combating extremely drug-resistant Gramnegative 'superbugs', Essays Biochem, vol.2017, pp.115-125, 2017.

L. L. Silver, Are natural products still the best source for antibacterial discovery? The bacterial entry factor, Expert Opinion on Drug Discovery, vol.172, issue.5, 2008.
DOI : 10.1021/jm00123a034

L. L. Silver, Challenges of Antibacterial Discovery, Clinical Microbiology Reviews, vol.24, issue.1, pp.71-109, 2011.
DOI : 10.1128/CMR.00030-10

B. Spellberg and D. Shlaes, Prioritized Current Unmet Needs for Antibacterial Therapies, Clinical Pharmacology & Therapeutics, vol.56, issue.2, 2014.
DOI : 10.1093/cid/cit070

R. A. Stavenger and M. Winterhalter, TRANSLOCATION Project: How to Get Good Drugs into Bad Bugs, Science Translational Medicine, vol.4, issue.20, 2014.
DOI : 10.1039/c2nr31024d

M. Thaker, P. Spanogiannopoulos, W. , and G. D. , The tetracycline resistome, Cellular and Molecular Life Sciences, vol.43, issue.3, pp.419-431, 2009.
DOI : 10.1128/AAC.38.4.637

R. Tommasi, D. G. Brown, G. K. Walkup, J. I. Manchester, and A. A. Miller, ESKAPEing the labyrinth of antibacterial discovery, Nature Reviews Drug Discovery, vol.5, issue.8, pp.529-542, 1038.
DOI : 10.1128/JB.02552-14

M. Vaara, Agents that increase the permeability of the outer membrane, Microbiol. Rev, vol.56, pp.395-411, 1992.

H. Venter, R. Mowla, T. Ohene-agyei, M. , and S. , RND-type drug e???ux pumps from Gram-negative bacteria: molecular mechanism and inhibition, Frontiers in Microbiology, vol.06, 2015.
DOI : 10.3389/fmicb.2015.00377

H. I. Zgurskaya, C. A. Löpez, and S. Gnanakaran, Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It, ACS Infectious Diseases, vol.1, issue.11, pp.512-522, 2015.
DOI : 10.1021/acsinfecdis.5b00097

J. Zhang, T. Chung, and K. A. Oldenburg, A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays, Journal of Biomolecular Screening, vol.4, issue.2, pp.67-73, 1999.
DOI : 10.1177/108705719900400206